Annals of the Rheumatic Diseases
Journal Abbreviation: ANN RHEUM DIS
ISSN: 0003-4967
eISSN: 1468-2060
Publisher: BMJ Publishing Group
Publications (483)
Low-dose blinatumomab in multidrug-resistant rheumatoid arthritis—a case series (2026)
Bucci L, Hagen M, Böltz S, Tur C, Nöthling DM, Dashi T, Auth J, et al.
Journal article
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133) (2026)
Petelytska L, Tofani L, Velauthapillai A, Dobrota R, Becker MO, Mihai C, Muraru S, et al.
Journal article
Human blood vessel organoids recapitulate key mechanisms of transition from vasculopathy to fibrosis in systemic sclerosis (2026)
Xiao Y, Hong X, Zhi L, Li YN, Regensburger M, Marxreiter F, Görg B, et al.
Journal article
Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups (2026)
Borrego-Yaniz G, Fuentes-Moreno V, Ortiz-Fernández L, Hernández-Rodríguez J, Mackie SL, Vaglio A, Castañeda S, et al.
Journal article
A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus (2026)
Nikolopoulos D, Pitsigavdaki S, Nöthling DM, Katechis S, Nikoloudaki M, Bergmann C, Silvagni E, et al.
Journal article
Bilirubin regulating the onset of rheumatoid arthritis (2026)
Otterbein N, Martinsson K, Schmid E, Heinen L, Park N, Danzer H, Dürholz K, et al.
Journal article
Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study (2026)
Torgutalp M, Almodovar R, Azevedo VF, Baraliakos X, Bosch FVd, Braun J, Chandran V, et al.
Journal article
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis (2026)
Makhzoum JP, Cid MC, Samson M, Henes J, Schönau V, Espigol-Frigole G, Ross C, et al.
Journal article
Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment (2026)
Papanikolaou S, Emmanouilidou E, Adamichou C, Kalogiannaki E, Nikolopoulos D, Fredi M, Carter LM, et al.
Journal article
Neutrophil transcriptomics in SLE reveals intrinsic disease signatures, shared ex vivo adaptation, and transcriptional reset after CAR T-cell therapy (2026)
Dehdashtian E, Hu G, Whiteman L, Islam MT, Gallucci S, Garber M, Borie D, et al.
Journal article